Cite
Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL)
MLA
Alessandro Re, et al. “Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL).” Blood, vol. 132, Nov. 2018, p. 401. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........72faab0f6a1e00c36be3a38c93f43e21&authtype=sso&custid=ns315887.
APA
Alessandro Re, Michael Mian, Sergio Cortelazzo, Alberto Zamò, Maria Gomes da Silva, Umberto Vitolo, Armando Santoro, Vittorio Stefoni, G. Ciccone, Filippo Ballerini, Simone Ferrero, Andrea Evangelista, Manuel Gotti, Marco Ladetto, Angela Coggi, Annalisa Chiappella, Chiara Rusconi, Franco Narni, Andrés J.M. Ferreri, … Federica Cavallo. (2018). Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL). Blood, 132, 401.
Chicago
Alessandro Re, Michael Mian, Sergio Cortelazzo, Alberto Zamò, Maria Gomes da Silva, Umberto Vitolo, Armando Santoro, et al. 2018. “Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL).” Blood 132 (November): 401. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........72faab0f6a1e00c36be3a38c93f43e21&authtype=sso&custid=ns315887.